Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Cash from Investing Activities (2016 - 2025)

Aytu Biopharma has reported Cash from Investing Activities over the past 11 years, most recently at -$17000.0 for Q4 2025.

  • Quarterly Cash from Investing Activities fell 111.72% to -$17000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.1 million through Dec 2025, down 794.18% year-over-year, with the annual reading at -$2.6 million for FY2025, 678.12% down from the prior year.
  • Cash from Investing Activities was -$17000.0 for Q4 2025 at Aytu Biopharma, up from -$3.0 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $381000.0 in Q3 2024 and troughed at -$3.1 million in Q4 2021.
  • The 5-year median for Cash from Investing Activities is -$57000.0 (2024), against an average of -$483166.7.
  • Year-over-year, Cash from Investing Activities tumbled 10070.0% in 2021 and then surged 601.32% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$3.1 million in 2021, then skyrocketed by 99.84% to -$5000.0 in 2022, then tumbled by 3380.0% to -$174000.0 in 2023, then soared by 183.33% to $145000.0 in 2024, then tumbled by 111.72% to -$17000.0 in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Cash from Investing Activities are -$17000.0 (Q4 2025), -$3.0 million (Q2 2025), and -$69000.0 (Q1 2025).